Update shared on 07 Nov 2025
Fair value Decreased 8.33%Analysts have lowered their price target for SunOpta from $9.60 to $8.80. They cited reduced revenue growth expectations and slightly lower projected profit margins as the reasons for this adjustment.
What's in the News
- SunOpta revised its full year 2025 earnings guidance, now expecting revenue of $812 million to $816 million. This is up from the previously expected range of $805 million to $815 million (Company guidance).
- The company issued new guidance for full year 2026, projecting revenue between $865 million and $880 million (Company guidance).
- SunOpta reported an unaudited impairment charge of $2.57 million related to property, plant, and equipment during the third quarter ended September 27, 2025 (Company report).
Valuation Changes
- Consensus Analyst Price Target decreased from $9.60 to $8.80.
- Discount Rate rose slightly from 6.78% to 6.96%.
- Revenue Growth fell notably from 9.45% to 7.75%.
- Net Profit Margin declined from 14.19% to 13.19%.
- Future P/E Ratio remained nearly unchanged, moving from 10.05x to 10.05x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.